Hepatobiliary Adverse Drug Reactions Associated With Remdesivir: The WHO International Pharmacovigilance Study

Kim, M. S., Jung, S. Y., Lee, S. W., Li, H., Koyanagi, A., Kronbichler, A., … Smith, L. (2021, September 1). Hepatobiliary Adverse Drug Reactions Associated With Remdesivir: The WHO International Pharmacovigilance Study. Clinical Gastroenterology and Hepatology. W.B. Saunders. https://doi.org/10.1016/j.cgh.2021.04.039